Disclosures
Royalties received from Peptilogics
Paid Consultant for Adaptive Phage Therapeutics, BiomX, Peptilogics, Smith & Nephew
Stock received from Osteal, Peptilogics
Support received from Peptilogics, Smith & Nephew
Board of Directors member for AAOS, ASTM, MSIS
All relevant financial disclosures have been mitigated.
Disclosures complete: Apr 30, 2024
*Please note that Global Link resources are not part of the CME offered for the 2025 ISAKOS Congress.